🚀 VC round data is live in beta, check it out!

U.S. Physical Therapy Valuation Multiples

Discover revenue and EBITDA valuation multiples for U.S. Physical Therapy and similar public comparables like Indegene, B-Soft Co., Netcare, Astrana Health and more.

U.S. Physical Therapy Overview

About U.S. Physical Therapy

US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.


Founded

1990

HQ

United States

Employees

7.0K

Website

usph.com

Financials (LTM)

Revenue: $791M
EBITDA: $97M

EV

$2B

Valuation Multiples

Multiples.vc

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

U.S. Physical Therapy Financials

U.S. Physical Therapy reported last 12-month revenue of $791M and EBITDA of $97M.

In the same LTM period, U.S. Physical Therapy generated $97M in EBITDA and $41M in net income.

Revenue (LTM)


U.S. Physical Therapy P&L

In the most recent fiscal year, U.S. Physical Therapy reported revenue of $781M and EBITDA of $110M.

U.S. Physical Therapy expects next 12-month revenue of XXX and NTM EBITDA of XXX

See U.S. Physical Therapy forward-looking valuation multiples
LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue$791MXXX$781MXXXXXXXXX
Gross Profit—XXX$150MXXXXXXXXX
Gross Margin—XXX19%XXXXXXXXX
EBITDA$97MXXX$110MXXXXXXXXX
EBITDA Margin12%XXX14%XXXXXXXXX
EBIT Margin11%XXX11%XXXXXXXXX
Net Profit$41MXXX$40MXXXXXXXXX
Net Margin5%XXX5%XXXXXXXXX
Net Debt——$127MXXXXXXXXX

Financial data powered by Morningstar, Inc.

U.S. Physical Therapy Stock Performance

U.S. Physical Therapy has current market cap of $1B, and enterprise value of $2B.

Market Cap Evolution


U.S. Physical Therapy's stock price is $83.03.

See U.S. Physical Therapy trading valuation data
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$2B$1B0.0%XXXXXXXXX$2.63

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

U.S. Physical Therapy Valuation Multiples

U.S. Physical Therapy trades at 1.9x EV/Revenue multiple, and 15.9x EV/EBITDA.

See valuation multiples for U.S. Physical Therapy and 15K+ public comps

EV / Revenue (LTM)


U.S. Physical Therapy Financial Valuation Multiples

As of March 7, 2026, U.S. Physical Therapy has market cap of $1B and EV of $2B.

Equity research analysts estimate U.S. Physical Therapy's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

U.S. Physical Therapy has a P/E ratio of 30.8x.

LTMNTMLast FYFY 2026FY 2027FY 2028
Market cap (current)$1BXXX$1BXXXXXXXXX
EV (current)$2BXXX$2BXXXXXXXXX
EV/Revenue1.9xXXX2.0xXXXXXXXXX
EV/EBITDA15.9xXXX14.0xXXXXXXXXX
EV/EBIT18.4xXXX18.7xXXXXXXXXX
EV/Gross Profit—XXX10.3xXXXXXXXXX
P/E30.8xXXX31.6xXXXXXXXXX
EV/FCF24.3xXXX25.2xXXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified U.S. Physical Therapy Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

U.S. Physical Therapy Margins & Growth Rates

U.S. Physical Therapy's revenue in the last 12 month grew by 7%.

U.S. Physical Therapy's revenue per employee in the last FY averaged $0.1M.

U.S. Physical Therapy's rule of 40 is 19% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

U.S. Physical Therapy's rule of X is 30% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for U.S. Physical Therapy and other 15K+ public comps

U.S. Physical Therapy Operational Valuation Multiples

LTMNTMLast FYFY 2026FY 2027FY 2028
Revenue Growth7%XXX7%XXXXXXXXX
EBITDA Margin12%XXX14%XXXXXXXXX
EBITDA Growth10%XXX(5%)XXXXXXXXX
Rule of 40—XXX19%XXXXXXXXX
Bessemer Rule of X—XXX30%XXXXXXXXX
Revenue per Employee—XXX$0.1MXXXXXXXXX
Opex to Revenue—XXX9%XXXXXXXXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

U.S. Physical Therapy Public Comps

See public comps and valuation multiples for other Hospitals & Clinics and Healthcare Software comps.

EV/RevenueEV/EBITDA
LTM2026E2027ELTM2026E2027E
IndegeneXXXXXXXXXXXXXXXXXX
B-Soft Co.XXXXXXXXXXXXXXXXXX
NetcareXXXXXXXXXXXXXXXXXX
Astrana HealthXXXXXXXXXXXXXXXXXX
Thomson MedicalXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXXXXXXX

Valuation data powered by FactSet, Inc.

U.S. Physical Therapy M&A Activity

U.S. Physical Therapy acquired XXX companies to date.

Last acquisition by U.S. Physical Therapy was on XXXXXXXX, XXXXX. U.S. Physical Therapy acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See M&A valuation multiples

Latest Acquisitions by U.S. Physical Therapy

Acquired CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.

Start Free Trial

U.S. Physical Therapy Investment Activity

U.S. Physical Therapy invested in XXX companies to date.

U.S. Physical Therapy made its latest investment on XXXXXXXX, XXXXX. U.S. Physical Therapy invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).

See VC round multiples

Latest Investments by U.S. Physical Therapy

CompanyValuationEV/RevenueEV/EBITDA
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX
XXXXXXXXXXXXXXXXXXXXX

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About U.S. Physical Therapy

When was U.S. Physical Therapy founded?U.S. Physical Therapy was founded in 1990.
Where is U.S. Physical Therapy headquartered?U.S. Physical Therapy is headquartered in United States.
How many employees does U.S. Physical Therapy have?As of today, U.S. Physical Therapy has over 7K employees.
Who is the CEO of U.S. Physical Therapy?U.S. Physical Therapy's CEO is Christopher J. Reading.
Is U.S. Physical Therapy publicly listed?Yes, U.S. Physical Therapy is a public company listed on NYSE.
What is the stock symbol of U.S. Physical Therapy?U.S. Physical Therapy trades under USPH ticker.
When did U.S. Physical Therapy go public?U.S. Physical Therapy went public in 1992.
Who are competitors of U.S. Physical Therapy?U.S. Physical Therapy main competitors are Indegene, B-Soft Co., Netcare, Astrana Health.
What is the current market cap of U.S. Physical Therapy?U.S. Physical Therapy's current market cap is $1B.
What is the current revenue of U.S. Physical Therapy?U.S. Physical Therapy's last 12 months revenue is $791M.
What is the current revenue growth of U.S. Physical Therapy?U.S. Physical Therapy revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of U.S. Physical Therapy?Current revenue multiple of U.S. Physical Therapy is 1.9x.
Is U.S. Physical Therapy profitable?Yes, U.S. Physical Therapy is EBITDA-positive (as of the last 12 months).
What is the current EBITDA of U.S. Physical Therapy?U.S. Physical Therapy's last 12 months EBITDA is $97M.
What is U.S. Physical Therapy's EBITDA margin?U.S. Physical Therapy's last 12 months EBITDA margin is 12%.
What is the current EV/EBITDA multiple of U.S. Physical Therapy?Current EBITDA multiple of U.S. Physical Therapy is 15.9x.
What is the current FCF of U.S. Physical Therapy?U.S. Physical Therapy's last 12 months FCF is $63M.
What is U.S. Physical Therapy's FCF margin?U.S. Physical Therapy's last 12 months FCF margin is 8%.
What is the current EV/FCF multiple of U.S. Physical Therapy?Current FCF multiple of U.S. Physical Therapy is 24.3x.

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial